Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tolnaftate is a synthetic thiocarbamate antifungal agent used topically to treat superficial fungal infections such as athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis). It is available over-the-counter in various formulations including creams, powders, sprays, gels, and solutions. Tolnaftate acts as a fungicide by inhibiting squalene epoxidase—an enzyme critical for ergosterol biosynthesis in fungi—leading to disruption of the fungal cell membrane. Its clinical use has declined with the advent of more potent antifungals but remains useful for mild to moderate dermatophyte infections[1][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tolnaftate.